Labcorp Return on Tangible Equity 2010-2024 | LH

Current and historical return on tangible equity values for Labcorp (LH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Labcorp Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-12-31 $0.75B $-1.81B -43.45%
2024-09-30 $0.44B $-1.85B -26.12%
2024-06-30 $0.45B $-1.55B -27.45%
2024-03-31 $0.43B $-1.65B -31.22%
2023-12-31 $0.42B $-1.61B -29.95%
2023-09-30 $0.66B $-1.73B -84.66%
2023-06-30 $0.83B $-0.55B -100.06%
2023-03-31 $1.00B $-1.69B -92.07%
2022-12-31 $1.28B $0.85B -125.52%
2022-09-30 $1.76B $-1.93B -110.69%
2022-06-30 $1.99B $-1.58B -143.42%
2022-03-31 $2.10B $-1.42B -160.60%
2021-12-31 $2.38B $-1.42B -177.92%
2021-09-30 $2.76B $-1.14B -178.22%
2021-06-30 $2.88B $-1.25B -137.75%
2021-03-31 $2.64B $-1.53B -95.67%
2020-12-31 $1.56B $-2.28B -45.13%
2020-09-30 $0.85B $-3.30B -21.33%
2020-06-30 $0.36B $-3.95B -8.46%
2020-03-31 $0.32B $-4.27B -7.16%
2019-12-31 $0.82B $-4.33B -18.50%
2019-09-30 $0.76B $-4.61B -16.99%
2019-06-30 $0.85B $-4.72B -19.75%
2019-03-31 $0.90B $-4.16B -21.11%
2018-12-31 $0.88B $-4.30B -19.90%
2018-09-30 $1.41B $-4.11B -31.02%
2018-06-30 $1.27B $-4.44B -25.67%
2018-03-31 $1.22B $-4.93B -24.74%
2017-12-31 $1.23B $-4.76B -25.74%
2017-09-30 $0.70B $-5.62B -15.11%
2017-06-30 $0.71B $-4.39B -16.42%
2017-03-31 $0.73B $-4.32B -16.97%
2016-12-31 $0.71B $-4.32B -16.37%
2016-09-30 $0.66B $-4.32B -14.90%
2016-06-30 $0.63B $-4.26B -14.02%
2016-03-31 $0.60B $-4.50B -12.74%
2015-12-31 $0.44B $-4.58B -8.90%
2015-09-30 $0.45B $-4.72B -10.63%
2015-06-30 $0.43B $-5.01B -12.36%
2015-03-31 $0.40B $-5.37B -14.76%
2014-12-31 $0.51B $-1.76B -26.88%
2014-09-30 $0.52B $-1.79B -26.01%
2014-06-30 $0.53B $-1.96B -25.77%
2014-03-31 $0.54B $-2.10B -26.41%
2013-12-31 $0.57B $-2.10B -29.30%
2013-09-30 $0.57B $-2.03B -29.96%
2013-06-30 $0.57B $-1.93B -30.75%
2013-03-31 $0.57B $-1.76B -32.01%
2012-12-31 $0.58B $-1.85B -33.15%
2012-09-30 $0.60B $-1.83B -34.26%
2012-06-30 $0.58B $-1.65B -34.15%
2012-03-31 $0.55B $-1.70B -31.98%
2011-12-31 $0.52B $-1.80B -29.16%
2011-09-30 $0.52B $-1.69B -28.95%
2011-06-30 $0.52B $-1.74B -31.70%
2011-03-31 $0.55B $-1.89B -36.82%
2010-12-31 $0.56B $-1.81B -42.56%
2010-09-30 $0.57B $-1.15B -49.80%
2010-06-30 $0.56B $-1.16B -48.79%
2010-03-31 $0.54B $-1.14B -48.94%
2009-12-31 $0.54B $-1.13B -48.69%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.166B $13.009B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $87.363B 23.91
Becton Dickinson (BDX) United States $57.057B 14.28
Cardinal Health (CAH) United States $32.542B 17.43
Straumann Holding AG (SAUHY) Switzerland $18.704B 0.00
Cooper (COO) United States $15.901B 21.09
West Pharmaceutical Services (WST) United States $14.596B 29.91
Align Technology (ALGN) United States $12.549B 24.31
Henry Schein (HSIC) United States $7.930B 13.66
Merit Medical Systems (MMSI) United States $5.369B 26.12
Patterson (PDCO) United States $2.772B 15.98
DENTSPLY SIRONA (XRAY) United States $2.557B 7.68
CONMED (CNMD) United States $1.503B 11.68
STAAR Surgical (STAA) United States $0.833B 0.00
Pro-Dex (PDEX) United States $0.198B 30.26
Lifevantage (LFVN) United States $0.169B 18.65